windows, version 145.8 (MedCalc Software Ltd)
90
Structured Review
MedCalc Software Ltd
windows, version 145.8
Windows, Version 145.8, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/windows%2C+version+145%2E8/windows++version+145+8/pmc09597885-173-18-21
Average 90 stars, based on 1 article reviews
Windows, Version 145.8, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/windows%2C+version+145%2E8/windows++version+145+8/pmc09597885-173-18-21
Average 90 stars, based on 1 article reviews
windows, version 145.8 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Continued Effectiveness of Relapse Prevention Cognitive-Behavioral Therapy Following Fluoxetine Treatment in Youth With Major Depressive Disorder Article Snippet: Statistical analyses were performed using SAS software, version 9.4 (SAS Institute, Cary, NC) as well as MedCalc for Article Title: Continued Effectiveness of Relapse Prevention Cognitive-Behavioral Therapy Following Fluoxetine Treatment in Youth With Major Depressive Disorder. Article Snippet: Objective: To evaluate the continued effect of a sequential treatment strategy (fluoxetine followed by continued medication plus relapse prevention cognitive-behavioral therapy [RP-CBT]) on relapse prevention beyond the treatment phase.. Method: Youth (aged 8–17 years) with major depressive disorder (MDD) were treated with fluoxetine for 6 weeks.. Responders (≥50% reduction on the Children’s Depression Rating Scale – Revised [CDRS-R]) were randomized to continued medication management alone (MM) or continued medication management plus RP-CBT (MM+CBT) for an additional 6 months. |